Low Expression of PLAT in Breast Cancer Infers Poor Prognosis and High Immune Infiltrating Level

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2022 Feb 28

PMID 35221711

Authors

Xinyang Wang

Dandan Xue

Xiaoxia Zhu

Rui Geng

Xin Bao

Xiang Chen

Tiansong Xia

Affiliations

Soon will be listed here.

Abstract

Purpose: Breast cancer accounts for the highest incidence of tumors in women. Immune infiltrating of the tumor microenvironment positively correlates with the overall survival of breast cancer patients. PLAT can affect the development of many cancers, but its mechanism in breast cancer is unclear. We assessed the correlation between PLAT and immune infiltrating in breast cancer based on the TCGA database.

Patients And Methods: The expression and DNA methylation of PLAT in breast cancer with different clinical characteristics was tested by Wilcoxon signed rank test and displayed by box plot. Sequentially, Kaplan-Meier plot was employed to compare the difference in overall survival rates between patients with different expressed levels. Univariate and multivariate Cox regression analyses were used to validate whether PLAT is an independent prognostic factor of breast cancer. After that, GO, KEGG, and gene-set enrichment analysis were employed to do functional enrichment analysis. Finally, TIMER, TISIDB database, and ssGSEA algorithm were used to assess the correlation between PLAT expression and various immune characteristics. The correlation between PLAT expression and DNA methylation was examined by Pearson correlation coefficient.

Results: PLAT displays differential expression levels in breast cancer patients with various clinical characteristics. As an independent protective factor for breast cancer, PLAT may significantly correlate with the immune status of breast cancer by adjusting many immune molecules and affecting the immune infiltration in the tumor microenvironment. DNA methylation of PLAT downregulates the gene expression and affects the prognosis of breast cancer.

Conclusion: PLAT can be considered a potential biomarker to predict breast cancer prognosis and might contribute to the development of immunological treatment strategies.

Citing Articles

Molecular subtype of gastric cancer based on apoptosis-related genes reveals differential immune microenvironment and intratumoral microorganisms distribution.

Yu X, Shao Y, Dong H, Yan J, Zhang X, Ye G BMC Cancer. 2025; 25(1):12.

PMID: 39762768 PMC: 11702164. DOI: 10.1186/s12885-024-13411-2.

RNA sequencing reveals transcriptomic changes in PC-12 cells following plasminogen activator, tissue type overexpression.

Mao Y, Fang C, Zhao J, Huang X, He W, Wang C Transl Cancer Res. 2024; 13(9):4866-4877.

PMID: 39430838 PMC: 11483446. DOI: 10.21037/tcr-24-326.

Integration of scRNA and bulk RNA-sequence to construct the 5-gene molecular prognostic model based on the heterogeneity of thyroid carcinoma endothelial cell.

Ni Z, Cong S, Li H, Liu J, Zhang Q, Wei C Acta Biochim Biophys Sin (Shanghai). 2024; 56(2):255-269.

PMID: 38186223 PMC: 10984871. DOI: 10.3724/abbs.2023254.

Exploring the shared gene signatures of smoking-related osteoporosis and chronic obstructive pulmonary disease using machine learning algorithms.

Wang H, Li S, Chen B, Wu M, Yin H, Shao Y Front Mol Biosci. 2023; 10:1204031.

PMID: 37251077 PMC: 10213920. DOI: 10.3389/fmolb.2023.1204031.

References

Santoni M, Romagnoli E, Saladino T, Foghini L, Guarino S, Capponi M . Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents. Biochim Biophys Acta Rev Cancer. 2017; 1869(1):78-84. DOI: 10.1016/j.bbcan.2017.10.007. View

Kidoguchi M, Noguchi E, Nakamura T, Ninomiya T, Morii W, Yoshida K . DNA Methylation of Proximal PLAT Promoter in Chronic Rhinosinusitis With Nasal Polyps. Am J Rhinol Allergy. 2018; 32(5):374-379. DOI: 10.1177/1945892418782236. View

Zhu J, Wan Y, Xu H, Wu Y, Hu B, Jin H . The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?. Cell Mol Life Sci. 2019; 76(8):1489-1506. PMC: 11105644. DOI: 10.1007/s00018-019-03005-8. View

Pitt J, Marabelle A, Eggermont A, Soria J, Kroemer G, Zitvogel L . Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol. 2016; 27(8):1482-92. DOI: 10.1093/annonc/mdw168. View

Ru B, Wong C, Tong Y, Zhong J, Zhong S, Wu W . TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019; 35(20):4200-4202. DOI: 10.1093/bioinformatics/btz210. View

Lester R, Jo M, Montel V, Takimoto S, Gonias S . uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol. 2007; 178(3):425-36. PMC: 2064849. DOI: 10.1083/jcb.200701092. View

Mootha V, Lindgren C, Eriksson K, Subramanian A, Sihag S, Lehar J . PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34(3):267-73. DOI: 10.1038/ng1180. View

Yan M, Wang W, Zhou J, Chang M, Peng W, Zhang G . Knockdown of enhances the anticancer effect of gefitinib in non-small cell lung cancer. J Thorac Dis. 2020; 12(3):712-723. PMC: 7139041. DOI: 10.21037/jtd.2019.12.106. View

Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf A . Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013; 39(4):782-95. DOI: 10.1016/j.immuni.2013.10.003. View

10.

Su S, Lin C, Yang W, Fan W, Yang S . The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies. Expert Opin Ther Targets. 2015; 20(5):551-66. DOI: 10.1517/14728222.2016.1113260. View

11.

Murciano-Goroff Y, Betof Warner A, Wolchok J . The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res. 2020; 30(6):507-519. PMC: 7264181. DOI: 10.1038/s41422-020-0337-2. View

12.

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q . TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020; 48(W1):W509-W514. PMC: 7319575. DOI: 10.1093/nar/gkaa407. View

13.

Gordon S, Maute R, Dulken B, Hutter G, George B, McCracken M . PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017; 545(7655):495-499. PMC: 5931375. DOI: 10.1038/nature22396. View

14.

Ohki M, Ohki Y, Ishihara M, Nishida C, Tashiro Y, Akiyama H . Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration. Blood. 2010; 115(21):4302-12. PMC: 2879105. DOI: 10.1182/blood-2009-08-236851. View

15.

Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

16.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

17.

Loi S, Sirtaine N, Piette F, Salgado R, Viale G, Van Eenoo F . Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. J Clin Oncol. 2013; 31(7):860-7. DOI: 10.1200/JCO.2011.41.0902. View

18.

Pena-Martinez C, Duran-Laforet V, Garcia-Culebras A, Ostos F, Hernandez-Jimenez M, Bravo-Ferrer I . Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance. Stroke. 2019; 50(11):3228-3237. DOI: 10.1161/STROKEAHA.119.026848. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Stanton S, Disis M . Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016; 4:59. PMC: 5067916. DOI: 10.1186/s40425-016-0165-6. View